For: | Lu JP, Wang J, Wang T, Wang Y, Wu WQ, Gao L. Microvessel density of malignant and benign hepatic lesions and MRI evaluation. World J Gastroenterol 2004; 10(12): 1730-1734 [PMID: 15188495 DOI: 10.3748/wjg.v10.i12.1730] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1730.htm |
Number | Citing Articles |
1 |
Atsushi Nanashima, Toshiyuki Nakayama, Yorihisa Sumida, Takafumi Abo, Hiroaki Takeshita, Kenichirou Shibata, Shigekazu Hidaka, Terumitsu Sawai, Toru Yasutake, Takeshi Nagayasu. Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(31): 4915-4922 doi: 10.3748/wjg.14.4915
|
2 |
Ahlam A. Abd Elmaksoud, Taghreed A.E. Abd Elazee. Role of c-Myc and CD34 oncoproteins expression in early and late phases of hepatocarcinogenesis. Egyptian Journal of Pathology 2011; 31(1): 25 doi: 10.1097/01.XEJ.0000398108.88640.3f
|
3 |
V. Laurent, S. Corby, L. Antunes, C. Barbary, S. Corby-Ciprian, E. Kermarrec, S. Béot, D. Régent. Foie et contraste des lésions focales : corrélation radio-histologique. Journal de Radiologie 2007; 88(7-8): 1036 doi: 10.1016/S0221-0363(07)89917-3
|
4 |
Ivan Chebib, Meer Taher Shabani-Rad, Michelle S. Chow, James Zhang, Zu-hua Gao. Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma with and without Cirrhosis. Biomarker Insights 2007; 2: 117727190700200 doi: 10.1177/117727190700200013
|
5 |
C.D. Marcus, V. Ladam-Marcus, C. Cucu, O. Bouché, L. Lucas, C. Hoeffel. Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives. Critical Reviews in Oncology/Hematology 2009; 72(3): 217 doi: 10.1016/j.critrevonc.2008.07.012
|
6 |
V. Laurent, J. Mathias, P.- A. Ganne, O. Bruot, D. Regent. Approche diagnostique devant une tumeur supposée bénigne du foie. Gastroentérologie Clinique et Biologique 2008; 32(5): S182 doi: 10.1016/j.gcb.2008.04.009
|
7 |
Stephen L Chan, Anthony TC Chan, Winnie Yeo. Role of α-Fetoprotein in Hepatocellular Carcinoma: Prognostication, Treatment Monitoring or Both?. Future Oncology 2009; 5(6): 889 doi: 10.2217/fon.09.64
|
8 |
Davide Roccarina, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World Journal of Hepatology 2015; 7(14): 1866-1874 doi: 10.4254/wjh.v7.i14.1866
|
9 |
Nola Hylton. Dynamic Contrast-Enhanced Magnetic Resonance Imaging As an Imaging Biomarker. Journal of Clinical Oncology 2006; 24(20): 3293 doi: 10.1200/JCO.2006.06.8080
|